Eskag Pharma Pvt. Ltd. is a trusted third-party manufacturing company in India, offering end-to-end pharma manufacturing and contract manufacturing pharma solutions for global B2B partners. With over five decades of experience in the pharma industry of India, we support brands with scalable, compliant, and market-ready pharmaceutical production.
Our WHO-GMP certified manufacturing facility in SIDCUL, Haridwar, along with our corporate base in Kolkata, enables consistent quality across regulated and semi-regulated markets. As a third-party medicine manufacturer, we focus on precision, documentation, and supply reliability.
As a leading third-party manufacturing company, Eskag Pharma offers pharma manufacturing across key therapeutic segments:
We support third-party manufacturing pharma requirements across these categories with a wide range of dosage forms, including tablets, capsules, syrups, suspensions, powders, creams, gels, and select injectable formulations.
Our pharma manufacturing processes ensure batch consistency, stability, and compliance with global regulatory standards.
Our contract manufacturing pharma services are designed to simplify product development and commercialisation:
As a third-party medicine manufacturer, we ensure that every stage meets regulatory and quality expectations to enable faster market entry and global acceptance.
Our pharma manufacturing facility in SIDCUL, Haridwar, is WHO-GMP, ISO 9001, and HACCP certified, enabling large-scale production with strict quality control.
We manufacture over 500 formulations across multiple categories, serving both domestic and export markets. With deep experience in the pharma industry of India, Eskag Pharma has established a strong presence across Africa, LATAM, Southeast Asia, the Middle East, and CIS countries.
As a third-party manufacturing company, we provide export-ready formulations backed by complete documentation and compliance support.
Our capabilities are designed to support product development, scalable manufacturing, and faster global market entry for our partners.
As a third-party medicine manufacturer, we ensure consistent quality, regulatory compliance, and reliable supply for long-term partnerships. We support large-scale pharma manufacturing with consistent batch production and export-ready documentation.
It can lead to quality issues, regulatory delays, and supply disruptions. Poor documentation or compliance may also impact product approval and brand credibility.
Manufacturers follow validated processes, controlled raw material sourcing, and strict quality checks. Batch records and stability studies ensure consistent product performance.
Documentation such as CTD, CoPP, COA, and stability data supports regulatory approval. It ensures compliance and enables smooth entry into domestic and export markets.
It removes the need for manufacturing infrastructure and regulatory setup. It also improves efficiency through scale, reducing overall production costs.
It offers cost-effective manufacturing, strong compliance, and large-scale production. This makes India a key supplier to both regulated and emerging markets.
Lead time depends on formulation complexity, raw material availability, batch size, and regulatory documentation. Clear specifications and ready approvals can significantly reduce turnaround time.